Model
Edge
Janux Therapeutics
0001864158
Filing Type
4
Filing Date
12/26/2024
Updated
12/27/24, 6:00 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership